Telehealth company Hims & Hers is pushing the boundaries of drug compounding and testing the limits of regulators.

The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, ...

Drug industry calls out telehealth company Hims & Hers' Super Bowl ad touting its knock-off weight loss medications.

Hims & Hers makes its Super Bowl commercial debut ... Glover), the commercial calls out weight loss prescriptions and the ...

BofA raised the firm’s price target on Hims & Hers to $21 from $18 and keeps an Underperform rating on the shares. The firm increased Q4 ...

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...

An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use of “affordable” compounded weight loss drugs.

Drug industry allies are calling out a Super Bowl ad touting its weight loss medications from telehealth company Hims & Hers, claiming the spot doesn't adequately disclose safety risks of these drugs.

“Hims & Hers offers life-changing weight-loss medications ... sent a letter to the Food and Drug Administration calling it a “deceptive advertisement” that failed to disclose side effects ...